These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 32522273

  • 1. Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial.
    Xu J, Wang R, You S, Zhang L, Zheng P, Ji G, Liu B.
    Trials; 2020 Jun 10; 21(1):512. PubMed ID: 32522273
    [Abstract] [Full Text] [Related]

  • 2. Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach.
    Dai L, Xu J, Liu B, Dang Y, Wang R, Zhuang L, Li D, Jiao L, Wang J, Zhang L, Zhong LLD, Zhou W, Ji G.
    Front Med; 2022 Oct 10; 16(5):745-759. PubMed ID: 35471471
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
    Wu QJ, Lv WL, Li JM, Zhang TT, Zhou WH, Zhang Q, Wang JC, Wang QN, Zhang RX, Zhao X, Chen ST, Liu S, Li GH, Cao ZM, Xu L, Chen J.
    Trials; 2020 Jun 05; 21(1):482. PubMed ID: 32503608
    [Abstract] [Full Text] [Related]

  • 4. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.
    Han K, Kwon O, Park HJ, Jung SY, Yang C, Son CG.
    Trials; 2020 Jan 31; 21(1):128. PubMed ID: 32005283
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial.
    Sun Y, Chen G, Chen S, Wang Y, Hu Y, Zhao Y.
    Trials; 2022 Jun 02; 23(1):455. PubMed ID: 35655225
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
    Tian PP, Wu QJ, Li J, Chen HW, Wu J, Deng YW, Xie ZC, Zhao W, Tan YQ.
    Trials; 2021 Nov 13; 22(1):798. PubMed ID: 34774099
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial.
    Huang Q, An Z, Xin X, Sun Q, Gao S, Lv S, Xu X, Yang S, Lu F, Yuan J, Zhao Y, Hu Y, Liu P, Feng Q.
    BMC Complement Med Ther; 2023 Apr 19; 23(1):126. PubMed ID: 37076843
    [Abstract] [Full Text] [Related]

  • 9. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
    Guo L, Yuan H, Zhang D, Zhang J, Hua Q, Ma X, Chen K.
    Medicine (Baltimore); 2020 May 22; 99(21):e20271. PubMed ID: 32481305
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial.
    Zhao L, Li M, Xu Y, Liu L, Zhang M, Chen G.
    Trials; 2019 Dec 30; 20(1):801. PubMed ID: 31888728
    [Abstract] [Full Text] [Related]

  • 11. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F, Namkhah Z, Tutunchi H, Rezayat SM, Mansouri S, Jazayeri-Tehrani SA, Yaseri M, Hosseinzadeh-Attar MJ.
    Trials; 2021 Nov 13; 22(1):801. PubMed ID: 34774104
    [Abstract] [Full Text] [Related]

  • 12. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J, Wu Y, Gong X, Ma Y, Yu S, Gao J.
    Trials; 2019 Aug 07; 20(1):481. PubMed ID: 31391092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
    Zhang XX, Chen WW, She B, Luo RJ, Shi N, Xue P, Yang XN, Xia Q.
    Trials; 2014 Jul 07; 15():272. PubMed ID: 25002101
    [Abstract] [Full Text] [Related]

  • 15. Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq.
    Zhu M, Hao S, Liu T, Yang L, Zheng P, Zhang L, Ji G.
    Oncotarget; 2017 Oct 10; 8(47):82621-82631. PubMed ID: 29137289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q, Zhou S, Li X, Chen Q, Lin W, Lu L, Li H, Chen C, Chen W, Li Y.
    Trials; 2019 Jan 18; 20(1):66. PubMed ID: 30658660
    [Abstract] [Full Text] [Related]

  • 19. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: Study protocol for a randomized controlled multicenter trial.
    Zhu Q, Kang J, Xu G, Li J, Zhou H, Liu Y.
    Medicine (Baltimore); 2020 Mar 18; 99(11):e19501. PubMed ID: 32176092
    [Abstract] [Full Text] [Related]

  • 20. Yishentongluo decoction in treatment of idiopathic asthenozoospermia infertility: Study protocol for a randomized controlled trial.
    Zhang Q, Fan L, Li F, Sun Z, Zhang C, Chen R.
    Medicine (Baltimore); 2020 Oct 23; 99(43):e22662. PubMed ID: 33120757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.